title: Anti-tumour necrosis factor alpha therapy in patients with impaired renal function.
authors.forename: Axel J
authors.initials: AJ
authors.lastname: Hueber
authors.forename: Andac
authors.initials: A
authors.lastname: Tunc
authors.forename: Georg
authors.initials: G
authors.lastname: Schett
authors.forename: Bernhard
authors.initials: B
authors.lastname: Manger
mesh_terms: D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003404:Creatinine / Q000097:blood; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000150:complications*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D003404:Creatinine